Countrymark Cooperative, Inc.; Withdrawal of Approval of NADA

Résumé

The Food and Drug Administration (FDA) is withdrawing approval of a new animal drug application (NADA) held by Countrymark Cooperative, Inc. The NADA provides for the use of tylosin Type A medicated articles to make Type C medicated feeds. Countrymark Cooperative requested the withdrawal of approval of the NADA because they are no longer making Type A medicated articles for use in Type C medicated feeds. In a final rule published elsewhere in this issue of the Federal Register, FDA is amending the regulations by removing those entries which reflect approval of the NADA.